<br>        Inclusion Criteria:<br><br>          -  Patients scheduled for curative (R0) resection<br><br>          -  No evidence of extrahepatic disease<br><br>          -  No history of previous hepatic lymphadenectomy<br><br>          -  Age equal or greater than 18 years<br><br>          -  Written Informed consent<br><br>        Exclusion Criteria:<br><br>          -  Expected lack of compliance<br><br>          -  Impaired mental state or language problems<br><br>          -  History of another primary cancer, except:<br><br>               -  Curatively treated in situ cervical cancer or curatively resected non-melanoma<br>                  skin cancer<br><br>               -  Other primary solid tumour curatively treated with no known active disease<br>                  present and no treatment administered for = 5 years prior to randomisation<br>      ;<br>        Inclusion Criteria:<br><br>          -  Patients scheduled for curative (R0) resection<br><br>          -  No evidence of extrahepatic disease<br><br>          -  No history of previous hepatic lymphadenectomy<br><br>          -  Age equal or greater than 18 years<br><br>          -  Written Informed consent<br><br>        Exclusion Criteria:<br><br>          -  Expected lack of compliance<br><br>          -  Impaired mental state or language problems<br><br>          -  History of another primary cancer, except:<br><br>               -  Curatively treated in situ cervical cancer or curatively resected non-melanoma<br>                  skin cancer<br><br>               -  Other primary solid tumour curatively treated with no known active disease<br>                  present and no treatment administered for = 5 years prior to randomisation<br>      ;<br>        Inclusion Criteria:<br><br>          -  Patients scheduled for curative (R0) resection<br><br>          -  No evidence of extrahepatic disease<br><br>          -  No history of previous hepatic lymphadenectomy<br><br>          -  Age equal or greater than 18 years<br><br>          -  Written Informed consent<br><br>        Exclusion Criteria:<br><br>          -  Expected lack of compliance<br><br>          -  Impaired mental state or language problems<br><br>          -  History of another primary cancer, except:<br><br>               -  Curatively treated in situ cervical cancer or curatively resected non-melanoma<br>                  skin cancer<br><br>               -  Other primary solid tumour curatively treated with no known active disease<br>                  present and no treatment administered for = 5 years prior to randomisation<br>      ;<br>        Inclusion Criteria:<br><br>          -  Patients scheduled for curative (R0) resection<br><br>          -  No evidence of extrahepatic disease<br><br>          -  No history of previous hepatic lymphadenectomy<br><br>          -  Age equal or greater than 18 years<br><br>          -  Written Informed consent<br><br>        Exclusion Criteria:<br><br>          -  Expected lack of compliance<br><br>          -  Impaired mental state or language problems<br><br>          -  History of another primary cancer, except:<br><br>               -  Curatively treated in situ cervical cancer or curatively resected non-melanoma<br>                  skin cancer<br><br>               -  Other primary solid tumour curatively treated with no known active disease<br>                  present and no treatment administered for = 5 years prior to randomisation<br>